These studies suggest that Nrf2 plays a key role in limiting the progression of NASH, which could be ascribed to the activation of antioxidative stress response genes but also to the modulation of fatty acid metabolism in hepatocytes. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.